Table 4.
Clinical outcomes of survivors and non-survivors
| Total (266) | Survivors (235) | Non-survivors (31) | p value | |
|---|---|---|---|---|
| LoH (day), median (IQR) | 22.0 (12.0–48.3) | 25.0 (15.0–54.0) | 8.0 (4.0–15.5) | <0.001 |
| LoICU (day), median (IQR) | 5.5 (3.0–14.0) | 5.0 (3.0–14.0) | 6.0 (4.0–14.0) | 0.36 |
| Mechanical Ventilation, n (%) | 166 (62) | 136 (58) | 30 (97) | <0.001 |
| DoMV (day), median (IQR) | 3.0 (0.0–9.0) | 2.0 (0.0–9.0) | 6.0 (3.0–14.0) | 0.001 |
| Emergency operation, n (%) | 92 (35) | 79 (34) | 18 (58) | 0.01 |
| Angioembolization, n (%) | 57 (21) | 48 (20) | 9 (29) | 0.35 |
| AKI, n (%) | 82 (31) | 60 (26) | 22 (71) | <0.001 |
| Hyperchloremia-48, n (%) | 65 (24) | 46 (20) | 19 (61) | <0.001 |
LoH length of hospital stay, IQR interquartile range, LoICU length of intensive care unit stay, DoMV duration of mechanical ventilation, AKI acute kidney injury, Hyperchloremia-48 hyperchloremia 48-h post-admission